The journal is dedicated to publishing original research that elucidates, or aims to modify, disease pathways and mechanisms–with the goal of advancing our knowledge in any biomedical discipline with relevance to human health. Together with EClinicalMedicine, EBioMedicine is part of The Lancet’s open access offering for quality biomedical research.

EBioMedicine publishes research papers investigating the basic determinants of human health and disease, the discovery and characterization of new therapeutic targets and treatments, and the identification of biomarkers and diagnostic tools which may help researchers and clinicians better understand and monitor disease. The journal also publishes relevant reviews, commentaries and opinion pieces.